|
Market Closed -
Euronext Bruxelles
09:25:00 26/08/2026 pm IST
|
After hours 12:11:04 am | |||
| 221.00 EUR | -1.38% |
|
220.70 | -0.14% |
| 20/08 | Cancer vaccines finally garner the spotlight |  |
| 19/08 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
| Market Cap | 4.27TCr 4.98TCr 4.01TCr 3.66TCr 6.91TCr 4,74800Cr 6.95TCr 47TCr 18TCr 2,39500Cr 19TCr 18TCr 7,93400Cr | P/E 2026 * |
22.4x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4.3TCr 5.01TCr 4.04TCr 3.69TCr 6.96TCr 4,78300Cr 7TCr 48TCr 19TCr 2,41300Cr 19TCr 18TCr 7,99100Cr | EV / Sales 2026 * |
4.95x | EV / Sales 2027 * | 4.23x |
| Free-Float |
61.59% | Yield 2026 * |
0.65% | Yield 2027 * | 0.67% |
Last Transcript: UCB
| 1 day | -1.38% | ||
| 1 week | +1.47% | ||
| Current month | -0.85% | ||
| 1 month | -10.09% | ||
| 3 months | -9.54% | ||
| 6 months | -11.03% | ||
| Current year | -7.38% |
| 1 week | 213.9 |  | 225.4 |
| 1 month | 211.6 | | 251.5 |
| Current year | 211.6 | | 289.5 |
| 1 year | 191.2 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 60 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/01/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 15/01/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 15/01/26 | Buy | Director | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | +1.47% | +10.64% | +168.92% | 4.99TCr | |
| -1.56% | -2.30% | +39.79% | -1.13% | 8.32TCr | |
| -7.68% | -16.13% | +491.39% | +28.48% | 6.34TCr | |
| -0.69% | +3.58% | -19.85% | -35.64% | 5.95TCr | |
| +0.76% | +3.53% | +0.08% | +36.18% | 5.29TCr | |
| -0.09% | -0.36% | +61.47% | -16.71% | 3.26TCr | |
| -0.48% | +0.71% | +54.03% | +99.57% | 2.63TCr | |
| +9.69% | +13.61% | +9.85% | +224.85% | 2.22TCr | |
| -1.15% | -0.30% | +60.29% | +121.68% | 1.72TCr | |
| -0.80% | -4.83% | +63.48% | +178.67% | 1.57TCr | |
| Average | -0.33% | +18.14% | +77.12% | +80.49% | 4.23TCr | |
| Weighted average by Cap. | -1.22% | +26.23% | +93.39% | +51.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 869.01Cr 1.01TCr 815.66Cr 744.96Cr 1.41TCr 97TCr 1.41TCr 9.65TCr 3.74TCr 49TCr 3.8TCr 3.72TCr 1,61400Cr | 968.38Cr 1.13TCr 908.92Cr 830.15Cr 1.57TCr 1,07600Cr 1.57TCr 11TCr 4.17TCr 54TCr 4.24TCr 4.14TCr 1,79800Cr |
| Net income | 192.52Cr 224.3Cr 180.7Cr 165.04Cr 311.47Cr 21TCr 312.97Cr 2.14TCr 828.74Cr 11TCr 842.2Cr 823.91Cr 36TCr | 232.74Cr 271.17Cr 218.45Cr 199.52Cr 376.54Cr 26TCr 378.36Cr 2.59TCr 1TCr 13TCr 1.02TCr 996.05Cr 43TCr |
| Net Debt | 31Cr 36Cr 29Cr 27Cr 50Cr 3.44TCr 50Cr 344.26Cr 133.41Cr 1.74TCr 135.58Cr 132.64Cr 5.75TCr | -180.56Cr -210.37Cr -169.47Cr -154.78Cr -292.11Cr -20TCr -293.52Cr -2.01TCr -777.24Cr -10TCr -789.86Cr -772.71Cr -34TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | €221.00 | -1.38% | 1,97,178 |
| 25/26/25 | €224.10 | +1.86% | 1,50,034 |
| 24/26/24 | €220.00 | -0.77% | 1,32,150 |
| 21/26/21 | €221.70 | +1.74% | 2,53,935 |
| 20/26/20 | €217.90 | +0.05% | 1,83,496 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions
